CW Advisors LLC Invests $289,000 in HealthEquity, Inc. $HQY

Key Points

• CW Advisors LLC bought 3,273 shares of HealthEquity, Inc. for approximately $289,000, signaling increased interest in the company's stock among institutional investors.
• HealthEquity's stock price opened at $88.29 with a market capitalization of $7.63 billion, while trading between a 52-week low of $73.84 and a high of $116.65.
• The company exceeded earnings estimates with $0.97 EPS for the quarter, prompting multiple analysts to upgrade their price targets and ratings for HealthEquity's stock.

CW Advisors LLC bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund bought 3,273 shares of the company's stock, valued at approximately $289,000.

Several other institutional investors also recently made changes to their positions in HQY. Versant Capital Management Inc purchased a new stake in shares of HealthEquity during the 1st quarter worth $28,000. Larson Financial Group LLC boosted its position in shares of HealthEquity by 1,366.0% during the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock worth $61,000 after purchasing an additional 642 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in shares of HealthEquity in the 1st quarter worth about $65,000. Whipplewood Advisors LLC boosted its position in shares of HealthEquity by 5,060.0% in the 1st quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock worth $68,000 after buying an additional 759 shares in the last quarter. Finally, UMB Bank n.a. boosted its position in shares of HealthEquity by 104.8% in the 1st quarter. UMB Bank n.a. now owns 848 shares of the company's stock worth $75,000 after buying an additional 434 shares in the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently commented on HQY. Raymond James Financial reiterated a "strong-buy" rating and issued a $120.00 price objective (up from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. JMP Securities boosted their price objective on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research report on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, June 5th. Finally, The Goldman Sachs Group boosted their price objective on shares of HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $117.82.

HealthEquity Trading Up 1.2%

Shares of NASDAQ:HQY traded up $1.04 during midday trading on Friday, reaching $89.33. The company's stock had a trading volume of 1,519,644 shares, compared to its average volume of 946,119. The firm has a market cap of $7.72 billion, a price-to-earnings ratio of 65.20, a price-to-earnings-growth ratio of 1.38 and a beta of 0.50. The business has a 50 day moving average price of $95.50 and a 200 day moving average price of $95.57. HealthEquity, Inc. has a 1 year low of $73.84 and a 1 year high of $116.65. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.16. The firm had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%.During the same period in the prior year, the business posted $0.80 earnings per share. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. Research analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Activity at HealthEquity

In related news, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction that occurred on Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the completion of the transaction, the executive vice president owned 53,225 shares of the company's stock, valued at approximately $5,414,579.25. This represents a 3.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jon Kessler sold 97,767 shares of the business's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.05, for a total transaction of $10,954,792.35. Following the sale, the director directly owned 75,000 shares of the company's stock, valued at $8,403,750. This represents a 56.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 291,744 shares of company stock worth $32,705,007. 1.50% of the stock is owned by company insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.